Zevra Therapeutics (ZVRA) Interest Coverage Ratio: History & Chart

Zevra Therapeutics, Inc.(ZVRA)

Biotechnology · Boston, MA

$10.73+0.03 (+0.28%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Zevra Therapeutics, Inc.

Zevra Therapeutics, Inc., founded in 2006 and based in Celebration, Florida, is a biopharmaceutical company dedicated to discovering and developing innovative treatments for rare diseases. The company employs its proprietary Ligand Activated Therapy (LAT) technology to create novel prodrug versions of existing FDA-approved medications or to enable new applications for other compounds, primarily addressing serious medical conditions within the United States. Zevra's development pipeline is strategically concentrated on high-unmet-need therapeutic areas, including attention deficit hyperactivity disorder (ADHD), stimulant use disorder, and various rare central nervous system (CNS) conditions, such as idiopathic hypersomnia (IH). Their lead product candidate, KP1077, which is a prodrug of d-methylphenidate (known as serdexmethylphenidate), is currently in Phase II clinical trials for the treatment of both IH and narcolepsy. Another key prodrug candidate, KP879, is also advancing through Phase II studies for stimulant use disorder. In addition to its pipeline, Zevra has successfully secured FDA approval for two products: AZSTARYS, a once-daily treatment for ADHD in patients aged six years and older, and APADAZ, an immediate-release combination product containing benzhydrocodone (a prodrug of hydrocodone) and acetaminophen. The company's product portfolio also includes arimoclomol, and it holds collaboration and licensing agreements with KVK-Tech, Inc. and Commave Therapeutics SA. Formerly known as KemPharm, Inc., the company officially rebranded to Zevra Therapeutics, Inc. in February 2023.

Boston, MA

61 employees

zevra.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Neil F. McFarlane

View full financials

ZVRA Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

-0.53x

INTEREST COVERAGE RATIO AVG TTM

-5.22x

INTEREST COVERAGE RATIO AVG 3Y

-19.06x

INTEREST COVERAGE RATIO AVG 5Y

-20.98x

INTEREST COVERAGE RATIO AVG 10Y

-10.11x

INTEREST COVERAGE RATIO AVG 15Y

N/A

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+89.85%

CURRENT VS 3Y AVG

+97.22%

CURRENT VS 5Y AVG

+97.47%

CURRENT VS 10Y AVG

+94.76%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

-6.38x

median of 528 covered companies

CURRENT VS SECTOR MEDIAN

+91.69%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Zevra Therapeutics, Inc. (ZVRA)	$634.30M	-0.53x	-5.22x	-19.06x	-20.98x
Prime Medicine, Inc. (PRME)vs ›	$632.16M	N/A	N/A	N/A	N/A
OmniAb, Inc. (OABI)vs ›	$630.63M	N/A	N/A	N/A	N/A
Aura Biosciences, Inc. (AURA)vs ›	$638.20M	N/A	N/A	N/A	N/A
SOPHiA GENETICS S.A. (SOPH)vs ›	$619.15M	-15.57x	N/A	N/A	N/A
4D Molecular Therapeutics, Inc. (FDMT)vs ›	$656.59M	N/A	N/A	N/A	N/A
Climb Bio, Inc. (CLYM)vs ›	$611.57M	N/A	N/A	N/A	N/A
Starling Oncology, Inc. (STLN)vs ›	$657.89M	-3.20x	N/A	N/A	N/A
Annexon, Inc. (ANNX)vs ›	$660.29M	N/A	N/A	N/A	N/A
Helus Pharma Inc. (HELP)vs ›	$666.95M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Zevra Therapeutics, Inc. (ZVRA)

$634.30M

-0.53x

-5.22x

-19.06x

-20.98x

Prime Medicine, Inc. (PRME)vs ›

$632.16M

N/A

OmniAb, Inc. (OABI)vs ›

$630.63M

N/A

Aura Biosciences, Inc. (AURA)vs ›

$638.20M

N/A

SOPHiA GENETICS S.A. (SOPH)vs ›

$619.15M

-15.57x

N/A

4D Molecular Therapeutics, Inc. (FDMT)vs ›

$656.59M

N/A

Climb Bio, Inc. (CLYM)vs ›

$611.57M

N/A

Starling Oncology, Inc. (STLN)vs ›

$657.89M

-3.20x

N/A

Annexon, Inc. (ANNX)vs ›

$660.29M

N/A

Helus Pharma Inc. (HELP)vs ›

$666.95M

N/A

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Zevra Therapeutics, Inc. (ZVRA)?

The interest coverage ratio for ZVRA stock is -0.53x.

Is Zevra Therapeutics, Inc.'s interest coverage ratio high or low?

The interest coverage ratio of -0.53x is 97% above its 5-year average of -20.98x, near the high end of its 5-year range (-687.97x–233.32x).

What is the TTM average interest coverage ratio for Zevra Therapeutics, Inc. (ZVRA)?

The TTM average interest coverage ratio for ZVRA stock is -5.22x.

What is the 3Y average interest coverage ratio for Zevra Therapeutics, Inc. (ZVRA)?

The 3Y average interest coverage ratio for ZVRA stock is -19.06x.

What is the 5Y average interest coverage ratio for Zevra Therapeutics, Inc. (ZVRA)?

The 5Y average interest coverage ratio for ZVRA stock is -20.98x.

What is the 10Y average interest coverage ratio for Zevra Therapeutics, Inc. (ZVRA)?

The 10Y average interest coverage ratio for ZVRA stock is -10.11x.

DATE	INTEREST COVERAGE RATIO
2026-03-31	5.16x
2025-12-31	4.78x
2025-09-30	2.02x
2025-06-30	-35.36x
2025-03-31	-2.72x
2024-12-31	-7.03x
2024-09-30	-11.81x
2024-06-30	-11.28x
2024-03-31	-27.87x
2023-12-31	-19.41x
2023-09-30	-41.98x
2023-06-30	-31.74x
2023-03-31	-70.50x
2022-12-31	-54.43x
2022-09-30	-53.44x
2022-06-30	-687.97x
2022-03-31	-371.80x
2021-12-31	-568.40x
2021-09-30	-370.33x
2021-06-30	233.32x
2021-03-31	19.94x
2020-12-31	-1.99x
2020-09-30	-0.70x
2020-06-30	1.46x
2020-03-31	-2.06x
2019-12-31	-2.37x
2019-09-30	2.05x
2019-06-30	-5.07x
2019-03-31	-7.41x
2018-12-31	-5.29x
2018-09-30	-10.61x
2018-06-30	-7.69x
2018-03-31	-8.06x
2017-12-31	-4.44x
2017-09-30	-5.23x
2017-06-30	-4.49x
2017-03-31	-4.03x
2016-12-31	-5.91x
2016-09-30	-5.68x
2016-06-30	-4.97x
2016-03-31	-6.06x
2015-12-31	-10.43x
2015-09-30	-5.56x
2015-06-30	-5.29x
2015-03-31	-4.90x
2014-12-31	-4.30x
2014-09-30	-25.08x
2014-06-30	-4.33x
2014-03-31	-16.38x

DATE

INTEREST COVERAGE RATIO

2026-03-31

5.16x

2025-12-31

4.78x

2025-09-30

2.02x

2025-06-30

-35.36x

2025-03-31

-2.72x

2024-12-31

-7.03x

2024-09-30

-11.81x

2024-06-30

-11.28x

2024-03-31

-27.87x

2023-12-31

-19.41x

2023-09-30

-41.98x

2023-06-30

-31.74x

2023-03-31

-70.50x

2022-12-31

-54.43x

2022-09-30

-53.44x

2022-06-30

-687.97x

2022-03-31

-371.80x

2021-12-31

-568.40x

2021-09-30

-370.33x

2021-06-30

233.32x

2021-03-31

19.94x

2020-12-31

-1.99x

2020-09-30

-0.70x

2020-06-30

1.46x

2020-03-31

-2.06x

2019-12-31

-2.37x

2019-09-30

2.05x

2019-06-30

-5.07x

2019-03-31

-7.41x

2018-12-31

-5.29x

2018-09-30

-10.61x

2018-06-30

-7.69x

2018-03-31

-8.06x

2017-12-31

-4.44x

2017-09-30

-5.23x

2017-06-30

-4.49x

2017-03-31

-4.03x

2016-12-31

-5.91x

2016-09-30

-5.68x

2016-06-30

-4.97x

2016-03-31

-6.06x

2015-12-31

-10.43x

2015-09-30

-5.56x

2015-06-30

-5.29x

2015-03-31

-4.90x

2014-12-31

-4.30x

2014-09-30

-25.08x

2014-06-30

-4.33x

2014-03-31

-16.38x

Interest Coverage Ratio: -0.53x

ZVRA Interest Coverage Ratio

ZVRA Average Interest Coverage Ratio Chart

ZVRA Current vs Average Interest Coverage Ratio Chart

ZVRA Interest Coverage Ratio Metrics

ZVRA Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

ZVRA Interest Coverage Ratio History

Related Metrics